Martina Cardi

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Ejection Fraction

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, Moritz Rau, Nikolaos Paschalidis, Rebecca Borella, Elena Santacroce, Annamaria Paolini, Lara Gibellini, Alin Liviu Ciobanu, Michela Cuccorese, Tommaso Trenti, Ignacio Rubio, Francesca Vitetta, Martina Cardi, Rafael Jose Argüello, Diana Ferraro, Andrea Cossarizza
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients. Nature communications 15 (1) (2024)
Sara De Biasi, Alin Liviu Ciobanu, Elena Santacroce, Domenico Lo Tartaro, Gianluca Degliesposti, Miriam D'Angerio, Maristella Leccese, Martina Cardi, Tommaso Trenti, Michela Cuccorese, Lara Gibellini, Diana Ferraro, Andrea Cossarizza
SARS-CoV-2 Vaccination Responses in Anti-CD20-Treated Progressive Multiple Sclerosis Patients Show Immunosenescence in Antigen-Specific B and T Cells. Vaccines 12 (8) (2024)
Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, Moritz Rau, Nikolaos Paschalidis, Rebecca Borella, Elena Santacroce, Annamaria Paolini, Lara Gibellini, Alin Liviu Ciobanu, Michela Cuccorese, Tommaso Trenti, Ignacio Rubio, Francesca Vitetta, Martina Cardi, Rafael Jose Argüello, Diana Ferraro, Andrea Cossarizza
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients. Nature communications 15 (1) (2024)
Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, Moritz Rau, Nikolaos Paschalidis, Rebecca Borella, Elena Santacroce, Annamaria Paolini, Lara Gibellini, Alin Liviu Ciobanu, Michela Cuccorese, Tommaso Trenti, Ignacio Rubio, Francesca Vitetta, Martina Cardi, Rafael Jose Argüello, Diana Ferraro, Andrea Cossarizza
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients. Nature communications 15 (1) (2024)